Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
Neurology and Therapy - United States
doi 10.1007/s40120-016-0042-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2016
Authors
Publisher
Springer Science and Business Media LLC